financetom
Business
financetom
/
Business
/
Prosperity Bancshares' Q1 Earnings, Revenue Fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Prosperity Bancshares' Q1 Earnings, Revenue Fall
Apr 24, 2024 6:31 AM

09:14 AM EDT, 04/24/2024 (MT Newswires) -- Prosperity Bancshares ( PB ) reported Q1 earnings Wednesday of $1.18 per diluted share, down from $1.37 a year earlier.

Analysts polled by Capital IQ expected $1.16.

Revenue for the quarter ended March 31, expressed as the sum of net interest income and total noninterest income, was $277.1 million, down from $281.7 million a year earlier.

Analysts surveyed by Capital IQ expected $276.4 million.

The company also retained a quarterly dividend of $0.56 per share, payable July 1 to shareholders of record on June 14.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
United Lithium Kicks Off Exploration Programs in Finland
United Lithium Kicks Off Exploration Programs in Finland
Jul 17, 2024
08:47 AM EDT, 07/17/2024 (MT Newswires) -- United Lithium ( ULTHF ) said Wednesday that it commenced the 2024 exploration program in early June on five of its properties in Finland covering 105,000 hectares. The program aims to identify lithium-cesium-tantalum-type pegmatites across the Kietyonmaki project, as well as the Kannus, Kova, Kast and Salkola property reservations. Our exploration efforts will...
Immutep Receives Dutch Regulatory Approval to Begin Human Testing of Potential Autoimmune Treatment
Immutep Receives Dutch Regulatory Approval to Begin Human Testing of Potential Autoimmune Treatment
Jul 17, 2024
08:45 AM EDT, 07/17/2024 (MT Newswires) -- Immutep ( IMMP ) said Wednesday it has received regulatory clearance from the Netherlands' ethics authority to begin human testing of its IMP761 potential autoimmune disease treatment. Immutep ( IMMP ) describes IMP761 as a LAG-3 agonist antibody to potentially treat rheumatoid arthritis, type 1 diabetes, and multiple sclerosis, among other autoimmune diseases....
First Atlantic Nickel Receives Drilling Permits Over Multiple Zones
First Atlantic Nickel Receives Drilling Permits Over Multiple Zones
Jul 17, 2024
08:48 AM EDT, 07/17/2024 (MT Newswires) -- First Atlantic Nickel Corp. ( FANCF ) on Wednesday said it has received drilling permits for 26 sites for its work and drilling program at the Atlantic Nickel Project in central Newfoundland. The 2024 exploration program currently underway is set to identify and test the most promising awaruite nickel zones along the established...
BioCardia Receives Patent for Morph DNA Transseptal Delivery
BioCardia Receives Patent for Morph DNA Transseptal Delivery
Jul 17, 2024
08:45 AM EDT, 07/17/2024 (MT Newswires) -- BioCardia ( BCDA ) said Wednesday that it was granted a patent for its method for transseptal access to the heart using a steerable catheter based on the company's Morph DNA technology. The patent issued by the US Patent Office protects the company's products through 2035, BioCardia ( BCDA ) said. BioCardia's (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved